Longterm treatment of destructive rheumatoid arthritis with methotrexate

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1881-1889

  Rau, Rolf ^a   Schleusser, Barbara ^a   Herborn, Gertraud ^a   Karger, Thomas ^a  

^a Evangelisches Fachkrankenhaus R ^*  (Germany)

Author keywords

Longterm treatment; Methotrexate; Radiographic progression; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; GOLD; METHOTREXATE; PREDNISONE;

ADULT; AGED; ALOPECIA; ARTICLE; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HEMOGLOBIN DETERMINATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; STOMATITIS; CLINICAL TRIAL; DISEASE COURSE; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030611582     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1992;35:138-45.
2. Weinblatt ME, Weissman BN, Holdsworth DE, et al: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum 1992;35:129-37.
3. Sany J, Anaya JM, Lussiez V, et al: Treatment of rheumatoid arthritis with methotrexate: A prospective open longterm study of 191 cases. J Rheumatol 1991;18:1323-7.
4. Hanrahan PS, Scrivens GA, Russell AS: Prospective longterm follow-up of methotrexate therapy in rheumatoid arthritis: Toxicity, efficacy and radiological progression. Br J Rheumatol 1989;28:147-53.
5. Alarcón GS, Tracy IC, Blackburn WD Jr: Methotrexate in rheumatoid arthritis: Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32:671-6.
6. Mielants H, Veys EM, van der Straeten C, Ackerman C, Goemaere S: The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: An open prospective study. J Rheumatol 1991;18:978-83.
7. Rau R, Herborn G, Karger T, Werdier D: Retardation of radiologie progression in rheumatoid arthritis with methotrexate therapy. Arthritis Rheum 1991;10:1236-44.
8. Karger T, Rau R: Behandlung der chronischen Polyarthritis mit niedrigdosiertem Methotrexat. (Treatment of rheumatoid arthritis with low dose methotrexate.) Dtsch med Wschr 1988;13:839-46.
9. Weinblatt M, Maier A, Blotner S, Coblyn J: Longterm prospective study of methotrexate in rheumatoid arthritis (abstr). Arthritis Rheum 1995;38:S265.
10. Weinblatt ME, Kaplan H, Germain BF: Methotrexate in rheumatoid arthritis: Effects on disease activity in a multicenter prospective study. J Rheumatol 1991;18:334-8.
11. Weinblatt ME, Kaplan H, Germain BF, et al: Methotrexate in rheumatoid arthritis: A five-year prospective multicenter study. Arthritis Rheum 1994;31:1492-8.
12. Ropes WN, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
13. Rau R, Herborn G: A modified version of Larsen's scoring method to assess radiologie changes in rheumatoid arthritis. J Rheumatol 1995;22:1976-82.
14. Rau R, Herborn G: Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy. Arthritis Rheum 1996;39:162-8.
15. World Health Organization: Handbook for reporting results of cancer treatment. Geneva: World Health Organisation, 1979.
16. Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis. A 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
17. Pincus T, Callahan LF: Methotrexate is significantly more likely to be continued over two years than gold salts, penicillamine or hydroxychloroquine in rheumatoid arthritis (abstr). Arthritis Rheum 1989;(suppl)32:128.
18. Morand EF, McCloud PI, Littlejohn GO: Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992;19:704-8.
19. Buchbinder R, Hall S, Sambrook PN, et al: Methotrexate therapy in rheumatoid arthritis: A life table review of 587 patients treated in community practice. J Rheumatol 1993;20:639-44.
20. Weinblatt ME, Trentham DE, Fraser PA: Longterm prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
21. Fehlauer CS, Carson CW, Cannon GW: Methotrexate therapy in rheumatoid arthritis: 2-year retrospective followup study. J Rheumatol 1989;16:307-12.
22. Segal AM, Koo AP, Calabrese LH: Twenty-year experience of methotrexate toxicity in rheumatoid arthritis (abstr). Arthritis Rheum 1987;(suppl)30:59.
23. Rau R, Frenzel H, Cepin A, Herborn G: 131 liver biopsies of MTX-treated RA patients compared with 135 pre-treatment biopsies (abstr). Arthritis Rheum 1992;35:S147.
24. Kremer JM, Lee JK: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986;29:822-31.
25. Kremer JM, Lee JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of fifty-three months. Arthritis Rheum 1988;31:477-584.
26. Sany J, Kaliski S, Couret M, Cuckacovich M, Daures J-P: Radiologic progression during intramuscular methotrexate treatment in rheumatoid arthritis. J Rheumatol 1990;17:1636-41.
27. Reykdal S, Steinsson K, Sigurjonsson K, et al: Methotrexate treatment of rheumatoid arthritis: Effects on radiological progression. Scand J Rheumatol 1989;18:221-6.